Investor Relations
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

SEC Filing Details

Document Details

Filing Date
Apr 30, 2018
Document Date
Apr 30, 2018
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
OPKO Health, Inc.